Covid-19 impact: Sale of cardiac, anti-diabetic drugs surge Ruchika Sharma18 July 2020 3:21 PM ISTThe sudden change in preferred therapies by masses has just taken a sharp turn from pre-Covid period when gastric, vitamin therapies were most widely...
Glenmark announces price reduction of 27pc for COVID drug FabiFlu Ruchika Sharma13 July 2020 2:01 PM ISTGlenmark has announced a price reduction of 27% for FabiFlu. The new MRP is INR 75 per tab from the earlier INR 103 per tab.
Glenmark accused of conspiring to fix prices for generic drugs in US Ruchika Sharma2 July 2020 10:52 AM ISTThe charge alleges that the gain to the conspirators, and the loss to the victims, was at least USD 200 million, it added.
Glenmark Pharma Net profit jumps 36pc to Rs 220 crore in Q4 Ruchika Sharma28 Jun 2020 10:15 AM ISTThe company's consolidated revenue for the quarter rose 7.96 percent to Rs 2,767.48 crore as against Rs 2,563.47 crore a year ago, Glenmark...
Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge Ruchika Sharma28 Jun 2020 9:15 AM ISTHe, however, added that the government has addressed the need to reduce import dependence by bringing in the bulk drug and medical devices policy.
Hindustan Unilever acquires Glenmark female hygiene brand VWash Ruchika Sharma27 Jun 2020 11:28 AM ISTHUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide, the company said.
Glenmark Favipiravir can be used in mild Covid cases, says doctor; Check out Consent Form Farhat Nasim22 Jun 2020 12:20 PM ISTMeanwhile, Glenmark has released a consent form. A copy of which is with Medical Dialogues. Entailing responsible medication use, the form should be...
Glenmark receives DGCI approval for launching Favipiravir in India Dr. Kamal Kant Kohli21 Jun 2020 6:14 PM ISTGlenmark Pharmaceuticals has received approvals from Drug Controller General of India to manufacture and market Favipiravir, an anti-viral drug, to...
Bharat Serums gets DCGI nod to test sepsis drug on Covid-19 patients Ruchika Sharma10 Jun 2020 1:37 PM ISTBharat Serums and Vaccines Ltd (BSVL) has received approval from the Drug Controller General of India (DCGI) to conduct phase-III clinical study on...
Glenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, Umifenovir Moderate COVID-19 hospitalised patients Ruchika Sharma26 May 2020 1:48 PM ISTThe new combination clinical trial will be called FAITH - (Favipiravir plus Umifenovir (efficacy & safety) Trial in an Indian Hospital setting)
Glenmark begins Phase 3 Clinical Trials on Antiviral Favipiravir for coronavirus in India Ruchika Sharma12 May 2020 12:57 PM ISTFavipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections
Glenmark Pharmaceuticals launches 3-in-1 inhaler therapy AIRZ-FF for COPD in India Ruchika Sharma11 May 2020 1:07 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. announced the launch of a Single Inhaler Triple Therapy AIRZ-FF - a combination of two bronchodilators,...
